AstraZeneca’s Vaccine, Dumped by the West, Helps Fill Gaping Need in Rest of World
LONDON— AstraZeneca PLC’s Covid-19 vaccine isn’t authorized in the U.S., and governments in Canada, Australia and across Western Europe have shunned it after production problems and rare but sometimes-deadly side effects.
In much of the rest of the world, though, it is a crucial workhorse vaccine, reaching more people in lower- and lower-middle-income countries than any other Western-made shot. It also has run neck and neck with a shot by China’s Sinovac Biotech Ltd. and one developed by Pfizer Inc. and Germany’s BioNTech SE for overall doses distributed globally.
